Evidence map›Paper›PMID 30568952›Full record

ArticleWorld journal of clinical cases2018

Probiotic Medilac-S

Ghania Sohail, Xiaoyu Xu, Mary C Christman, Thomas A Tompkins

Open access · diamondAbstract read
In one paragraph

Article in World journal of clinical cases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Efficacy of interventions with live combinedFrontiers in pharmacology · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. [E.faecium QH06 alleviates TNBS-induced colonic mucosal injury in rats].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  7. Review
  8. Gastroenterology research and practice · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ghania SohailLallemand Health Solutions Inc., Montreal, QC H4P 2R2, Canada.
Xiaoyu XuLallemand Health Solutions Inc., Montreal, QC H4P 2R2, Canada.
Mary C ChristmanMCC Statistical Consulting, Gainesville, FL 32605, United States.
Thomas A TompkinsLallemand Health Solutions Inc., Montreal, QC H4P 2R2, Canada. ttompkins@lallemand.com.
Statistical Research (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo assess the effects of probiotic Medilac-S

methodsA systematic literature search was conducted to find randomized, controlled trials in a Chinese population with at least two study arms - a control arm which receives a conventional, oral aminosalicylate drug, and a treatment arm, which administers the same conventional drug in conjunction with the probiotic Medilac-S

resultsFifty-three clinical trials with a total of 3984 participants were identified and included in the review. Medilac-S

conclusionEvidence suggests Medilac-S

Indexed as

Clinical remissionMedilac-S®MesalazineMeta-analysisSulfasalazineSystematic reviewUlcerative colitis

Identifiers

PMID30568952
PMCPMC6288505
OpenAlexW2904846425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.